BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8645006)

  • 1. Control of hemoglobin synthesis in erythroid differentiating K562 cells. I. Role of iron in erythroid cell heme synthesis.
    Kawasaki N; Morimoto K; Tanimoto T; Hayakawa T
    Arch Biochem Biophys; 1996 Apr; 328(2):289-94. PubMed ID: 8645006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of hemoglobin synthesis in erythroid differentiating K562 cells. II. Studies of iron mobilization in erythroid cells by high-performance liquid chromatography-electrochemical detection.
    Kawasaki N; Morimoto K; Hayakawa T
    J Chromatogr B Biomed Sci Appl; 1998 Feb; 705(2):193-201. PubMed ID: 9521555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of extracellular hemin on hemoglobin and ferritin content of erythroleukemia cells.
    Fibach E; Konijn AM; Bauminger RE; Ofer S; Rachmilewitz EA
    J Cell Physiol; 1987 Mar; 130(3):460-5. PubMed ID: 3470297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, inhibits erythropoietin-induced erythroid differentiation of K562 cells.
    Kubota Y; Tanaka T; Yamaoka G; Yamaguchi M; Ohnishi H; Kawanishi K; Takahara J; Irino S
    Leukemia; 1996 Apr; 10(4):720-6. PubMed ID: 8618453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL; Wu RT
    Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of heme synthesis decreases transferrin receptor expression in mouse erythroleukemia cells.
    Hradilek A; Fuchs O; Neuwirt J
    J Cell Physiol; 1992 Feb; 150(2):327-33. PubMed ID: 1734036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells.
    Berkovitch-Luria G; Yakobovitch S; Weitman M; Nudelman A; Rozic G; Rephaeli A; Malik Z
    Eur J Pharm Sci; 2012 Aug; 47(1):206-14. PubMed ID: 22705251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cells.
    Weidner DA; Bridges EG; Cretton EM; Sommadossi JP
    Mol Pharmacol; 1992 Feb; 41(2):252-8. PubMed ID: 1538705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational control of erythroid delta-aminolevulinate synthase in immature human erythroid cells by heme.
    Smith SJ; Cox TM
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):103-14. PubMed ID: 9074795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense src expression inhibits proliferation and erythropoietin-induced erythroid differentiation of K562 human leukemia cells.
    Kitanaka A; Waki M; Kamano H; Tanaka T; Kubota Y; Ohnishi H; Takahara J; Irino S
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1534-40. PubMed ID: 7517673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
    Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
    Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythroid properties of K562 cells. Effect of hemin, butyrate and TPA induction.
    Villeval JL; Pelicci PG; Tabilio A; Titeux M; Henri A; Houesche F; Thomopoulos P; Vainchenker W; Garbaz M; Rochant H; Breton-Gorius J; Edwards PA; Testa U
    Exp Cell Res; 1983 Jul; 146(2):428-35. PubMed ID: 6575918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of heme synthesis during Friend cell differentiation: role of iron and transferrin.
    Laskey JD; Ponka P; Schulman HM
    J Cell Physiol; 1986 Nov; 129(2):185-92. PubMed ID: 3464611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin controls heme metabolic enzymes in normal human bone marrow culture.
    Abraham NG; Nelson JC; Ahmed T; Konwalinka G; Levere RD
    Exp Hematol; 1989 Sep; 17(8):908-13. PubMed ID: 2767184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferrochelatase, glutathione peroxidase and transferrin receptor mRNA synthesis and levels in mouse erythroleukemia cells.
    Fuchs O
    Stem Cells; 1993 May; 11 Suppl 1():13-23. PubMed ID: 8318915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hemoglobin accumulation by monoclonal antibodies to the human transferrin receptor is reversed by hemin.
    Viola L; Biagini R; Barbieri R; Gambari R
    Exp Hematol; 1987 Dec; 15(11):1145-52. PubMed ID: 2445597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of the globin genes in human leukemia K562(S) cells induced to differentiate by hemin or butyric acid.
    Cioe L; McNab A; Hubbell HR; Meo P; Curtis P; Rovera G
    Cancer Res; 1981 Jan; 41(1):237-43. PubMed ID: 6934848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3'-Azido-3'-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-562 human leukemia cells.
    Weidner DA; Sommadossi JP
    Mol Pharmacol; 1990 Dec; 38(6):797-804. PubMed ID: 2174502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hemoglobin expression by heterologous production of nitric oxide synthase in the K562 erythroleukemic cell line.
    Rafferty SP; Domachowske JB; Malech HL
    Blood; 1996 Aug; 88(3):1070-8. PubMed ID: 8704216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of i- and I-antigen expression in the K562 cell line.
    Testa U; Henri A; Bettaieb A; Titeux M; Vainchenker W; Tonthat H; Docklear MC; Rochant H
    Cancer Res; 1982 Nov; 42(11):4694-700. PubMed ID: 6751526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.